The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

PERSPECTIVES

Valve durability – is this the Achilles’ heel of TAVI?

EuroIntervention 2019;14:e1544-e1547. DOI: 10.4244/EIJV14I15A263

1. Imperial College Healthcare Trust, London, United Kingdom; 2. Imperial College London, London, United Kingdom


Introduction

Transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of severe aortic stenosis and is now the default option for patients with elevated surgical risk. Since the first valve implantation in 2002, there have been dramatic improvements in both technical/procedural aspects and equipment used which have naturally led to improved outcomes1,2. The procedure has evolved and become streamlined with “minimal” TAVI performed in many centres. Preprocedural computed tomography (CT) sizing, procedural use of conscious sedation, lower profile sheaths and improvements in vascular closure devices have led to mortality and morbidity reductions and earlier discharge times (often within 48 ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Transcatheter aortic valve implantation (TAVI) in Germany: more than 100,000 procedures and now the standard of care for the elderly